PURPOSE Antibiotics are only benefi cial for subgroups of patients with acute lower respiratory tract infections (LRTI) and rhinosinusitis in family practice, yet overprescribing for these conditions is common. C-reactive protein (CRP) pointof-care testing and delayed prescribing are useful strategies to reduce antibiotic prescribing, but both have limitations. We evaluated the effect of CRP assistance in antibiotic prescribing strategies-including delayed prescribing-in the management of LRTI and rhinosinusitis.
METHODSWe conducted a randomized controlled trial in which 258 patients were enrolled (107 LRTI and 151 rhinosinusitis) by 32 family physicians. Patients were individually randomized to CRP assistance or routine care (control). Primary outcome was antibiotic use after the index consultation. Secondary outcomes included antibiotic use during the 28-day follow-up, patient satisfaction, and clinical recovery.
RESULTSPatients in the CRP-assisted group used fewer antibiotics (43.4%) than control patients (56.6%) after the index consultation (relative risk [RR] = 0.77; 95% confi dence interval [CI], 0.56-0.98). This difference remained signifi cant during follow-up (52.7% vs 65.1%; RR = 0.81; 95% CI, 0.62-0.99). Delayed prescriptions in the CRP-assisted group were fi lled only in a minority of cases (23% vs 72% in control group, P <.001). Recovery was similar across groups. Satisfaction with care was higher in patients managed with CRP assistance (P = .03).CONCLUSIONS CRP point-of-care testing to assist in prescribing decisions, including delayed prescribing, for LRTI and rhinosinusitis may be a useful strategy to decrease antibiotic use and increase patient satisfaction without compromising patient recovery. Ann Fam Med 2010;8:124-133. doi:10.1370/afm.1090.
INTRODUCTIONR espiratory tract infections are among the most common reasons to consult in family practice. Although antibiotic treatment is considered necessary only for community-acquired pneumonia and for small subgroups of the other lower and upper respiratory tract infections, [1][2][3][4][5] antibiotics are prescribed to roughly 80% of patients consulting for lower respiratory tract infection (LRTI) or acute rhinosinusitis. 6,7 Signs and symptoms are of limited value in identifying those patients in need of antibiotic treatment for these conditions. 2,[8][9][10] Diagnostic uncertainty and patient-related factors, such as patient expectations and pressure, often lead to unjustifi ed antibiotic prescribing by family physicians. 11,12 C-reactive protein (CRP) is an acute-phase protein with levels quickly rising during infl ammatory processes. Currently, CRP can be measured by using a point-of-care test, which has been proved both accurate and robust in a family practice setting. 13
T ES T ING CR P F OR A N T IBIOT IC PR ES CR IBINGparameters, increases diagnostic certainty [14][15][16] and may thereby help identify those patients who will benefi t from antibiotic treatment. Latest randomized evidence has shown that antibiotic prescribing rates ...